PULSE BIOSCIENCES, INC. (PLSE)
$0.00+$0.00 (+0.00%) TodayExtended Hours
Robert W. Duggan - DirectorPulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
https://www.pulsebiosciences.comSEC filings for PLSE on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 12 | 1,389,215 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
31 Form 4 filings on record, the earliest from Dec 14, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Liane Rae Teplitsky - Officer | Grant or award | Restricted Stock Units | 200,000 | $0.00 | - | |
| Liane Rae Teplitsky - Officer | Grant or award | Stock Option (right to buy) | 700,000 | $0.00 | - | |
| Jon Skinner - Officer | Grant or award | Stock Option (right to buy) | 300,000 | $0.00 | - | |
| Mahkam Zanganeh - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Mahkam Zanganeh - Director | Grant or award | Stock Option (right to buy) | 14,504 | $0.00 | - | |
| Den Broek Richard van - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Den Broek Richard van - Director | Grant or award | Stock Option (right to buy) | 8,423 | $0.00 | - | |
| Robert W. Duggan - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Robert W. Duggan - Director | Grant or award | Stock Option (right to buy) | 12,495 | $0.00 | - | |
| Manmeet Singh Soni - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Maria Sainz - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Maria Sainz - Director | Grant or award | Stock Option (right to buy) | 3,793 | $0.00 | - | |
| Robert W. Duggan - Director | Open-market purchase | Common Stock | 660,233 | $19.69 | $13.00M | |
| Paul A. Laviolette - Officer | Open-market purchase | Common Stock | 15,000 | $19.69 | $295K | |
| Paul A. Laviolette - Officer | Open-market purchase | Common Stock | 15,000 | $19.69 | $295K | |
| Robert W. Duggan - Director | Open-market purchase | Common Stock | 660,233 | $19.69 | $13.00M | |
| Darrin Uecker - Officer | Grant or award | Restricted Stock Units | 100,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 5,000 | $1.53 | $8K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 5,000 | $23.64 | $118K | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 5,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $23.37 | $467K | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $23.53 | $471K | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $23.63 | $473K | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $21.45 | $429K | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $23.52 | $470K | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $25.20 | $504K | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Maria Sainz - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Maria Sainz - Director | Grant or award | Stock Option (right to buy) | 3,104 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 4,600 | $1.53 | $7K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 4,600 | $18.53 | $85K | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 4,600 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $18.49 | $370K | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 400 | $1.53 | $612 | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 400 | $18.48 | $7K | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 400 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 25,000 | $4.00 | $100K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 25,000 | $16.28 | $407K | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 20,000 | $4.00 | $80K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 20,000 | $16.21 | $324K | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 61,534 | $4.00 | $246K | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 100,000 | $4.00 | $400K | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 61,534 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 25,000 | $4.00 | $100K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 25,000 | $14.78 | $370K | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 25,000 | $4.00 | $100K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 25,000 | $14.32 | $358K | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 25,000 | $4.00 | $100K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 25,000 | $15.77 | $394K | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Robert W. Duggan - Director | Open-market purchase | Common Stock | 34,659 | $14.66 | $508K | |
| Robert W. Duggan - Director | Open-market purchase | Common Stock | 12,800 | $14.77 | $189K | |
| Robert W. Duggan - Director | Open-market purchase | Common Stock | 145,140 | $14.41 | $2.09M | |
| Manmeet Singh Soni - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Robert W. Duggan - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Robert W. Duggan - Director | Grant or award | Stock Option (right to buy) | 20,792 | $0.00 | - | |
| Mahkam Zanganeh - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Mahkam Zanganeh - Director | Grant or award | Stock Option (right to buy) | 24,134 | $0.00 | - | |
| Den Broek Richard van - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Steven Weber - Officer | Grant or award | Stock Option (right to buy) | 55,000 | $0.00 | - | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 15,000 | $16.40 | $246K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 15,000 | $15.98 | $240K | |
| Burke Thomas Barrett | Open-market sale | Common Stock | 50,000 | $17.42 | $871K | |
| Robert W. Duggan | Other | Common Stock | 5,187,824 | $11.00 | $57.07M | |
| Robert W. Duggan | Other | Common Stock | 69,020 | $11.00 | $759K | |
| Robert W. Duggan | Other | Common Stock | 49,312 | $11.00 | $542K | |
| Robert W. Duggan | Other | Warrants (right to buy) | 2,593,912 | - | - | |
| Robert W. Duggan | Other | Warrants (right to buy) | 2,593,912 | - | - | |
| Robert W. Duggan | Other | Warrants (right to buy) | 34,510 | - | - | |
| Robert W. Duggan | Other | Warrants (right to buy) | 34,510 | - | - | |
| Robert W. Duggan | Other | Warrants (right to buy) | 24,656 | - | - | |
| Robert W. Duggan | Other | Warrants (right to buy) | 24,656 | - | - | |
| Robert W. Duggan | Open-market purchase | Common Stock | 45,404 | $17.13 | $778K |
PULSE BIOSCIENCES, INC. (PLSE) had 7 insider filings in the last 90 days, with the most recent on 2026-08-28. The full record for PLSE runs to 31 Form 4 filings, the earliest from 2024-12-14. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of PLSE were filed in the last 90 days. 10 purchases are on record for this company.
No insider sales of PLSE were filed in the last 90 days. 18 sales are on record for this company.
This page tracks PLSE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add PLSE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
